Skip to main content

Table 2 Factors related to provision of IPTp in health facilities

From: Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors

Variable Urban Rural Total (%)
  Public Private Public Private  
  11 3 17 3 34
How IPTp is delivered
 IPTp is offered in the facility 10 2 15 2 29 (85.3)
 DOT is practiced in the facility 3 1 3 0 7 (20.6)
 Woman is given drug to take home 7 1 12 2 22 (64.7)
Where drug used for IPTp is sourced
 Free from Ministry of Health 10 0 15 0 25 (73.5)
 Purchased 0 2 0 2 4 (11.7)
Facility occasionally has periods of drug stock-out 6 1 4 1 12 (35.3)
Source of drugs during stock-out
 Direct acquisition from market for sale 1 1 1 1 4 (11.8)
 Woman is given prescription to purchase on her own 5 0 3 0 8 (23.5)
Facilities with drugs on day of interview
 SP 11 3 15 3 32 (94.1)
 ACT 8 3 16 3 30 (88.2)
 Quinine 7 1 5 3 16 (47.1)
Complaints about the drug
 Side effect 1 2 2 1 6 (17.6)
 Irregularity of drug availability 0 0 2 0 2 (5.9)